Gufic Biosciences Limited (BOM:509079)
271.05
-7.80 (-2.80%)
At close: Mar 4, 2026
Gufic Biosciences Revenue
Gufic Biosciences had revenue of 2.31B INR in the quarter ending December 31, 2025, with 11.37% growth. This brings the company's revenue in the last twelve months to 8.97B, up 10.80% year-over-year. In the fiscal year ending March 31, 2025, Gufic Biosciences had annual revenue of 8.20B with 1.63% growth.
Revenue (ttm)
8.97B
Revenue Growth
+10.80%
P/S Ratio
3.11
Revenue / Employee
6.05M
Employees
1,484
Market Cap
27.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 8.20B | 131.40M | 1.63% |
| Mar 31, 2024 | 8.07B | 1.16B | 16.80% |
| Mar 31, 2023 | 6.91B | -885.35M | -11.36% |
| Mar 31, 2022 | 7.79B | 2.91B | 59.76% |
| Mar 31, 2021 | 4.88B | 1.09B | 28.74% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Unichem Laboratories | 22.14B |
| FDC Limited | 20.78B |
| Morepen Laboratories | 17.87B |
| Hikal | 17.46B |
| Bliss GVS Pharma | 8.68B |
| TTK Healthcare | 8.30B |
| Lincoln Pharmaceuticals | 6.52B |
| Amrutanjan Health Care | 4.88B |
Gufic Biosciences News
- 13 days ago - Gufic Biosciences Ltd (BOM:509079) Q3 2026 Earnings Call Highlights: Resilient Turnover Amid ... - GuruFocus
- 13 days ago - Q3 2026 Gufic Biosciences Ltd Earnings Call Transcript - GuruFocus
- 3 months ago - Gufic Biosciences Ltd (BOM:509079) Q2 2026 Earnings Call Highlights: Steady Revenue Growth and ... - GuruFocus
- 3 months ago - Q2 2026 Gufic Biosciences Ltd Earnings Call Transcript - GuruFocus
- 1 year ago - Gufic Biosciences Ltd (BOM:509079) Q3 2025 Earnings Call Highlights: Navigating Profitability ... - GuruFocus
- 1 year ago - Q3 2025 Gufic Biosciences Ltd Earnings Call Transcript - GuruFocus